Four repurposed drugs have little to no effect on Covid, says WHO | India News

Four repurposed drugs have little to no effect on Covid, says WHO | India News

Create your Web Presence with Namecheap5618 Four repurposed drugs have little to no effect on Covid, says WHO | India News

NEW DELHI: The multi-country solidarity trial led by the World Health Organization (WHO) has concluded that none of the four repurposed drugs that it examined — Remdesivir, Hydroxychloroquine (HCQ), Lopinavir and Interferon — have any benefits on the patients of Covid-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay.
At present, the clinical management protocol for Covid-19 in India recommends use of Remdesivir as an investigational therapy and HCQ as an off-label repurposed therapy for treatment.
“These Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized Covid-19 patients, as indicated by overall mortality, initiation of ventilation and duration of hospital stay. The mortality findings contain most of the randomized evidence on Remdesivir and Interferon, and are consistent with meta-analyses of mortality in all major trials,” researchers from the Solidarity trial reported.
The results of the study are under review for publication. A preprint is available at medRxiv.
The trial was conducted in 405 hospitals in 30 countries involving 11,266 adults.

20200221101654 Four repurposed drugs have little to no effect on Covid, says WHO | India Newsaff i?offer id=2792&file id=192733&aff id=6414 Four repurposed drugs have little to no effect on Covid, says WHO | India News



You must be logged in to post a comment Login